Tanner Pharma Group To Attend Upcoming CPHI Worldwide Conference

For Immediate Release

Contact:
Lindsey Stevens
Tanner Pharma Group
704-552-8407
lstevens@tannerpharma.com

CHARLOTTE, N.C. – Top executives from Tanner Pharma Group (“Tanner Pharma”), a Charlotte-based global pharmaceutical services company, will attend the CPhI Worldwide event on October 24 – 26 in Messe Frankfurt, Germany.

Tanner Pharma leverages more than 15 years of pharma services experience to provide regulatory compliance and logistical efficiency, all within an EU-GDP compliant supply chain. The company provides services through four complimentary divisions located in the U.S. and U.K.; TannerCTS, clinical trial services; TannerLAC, licensing, acquisition and commercialization; TannerGAP, global access programs; and TannerMAP, managed access programs.

Tanner Pharma representatives will include Richard Lambie, Global Director of Clinical Trial Sourcing for TannerCTS, Jonathan Bracey, Managing Director UK – SVP of Corporate Development, and Joanne Stannard, Project Manager for TannerCTS.

Individuals who wish to schedule a meeting with representatives from Tanner Pharma may contact:
United Kingdom: Ancilla Andrew | aandrew@tannerpharma.com | +44 (0) 20 3940 8111
United States: Brittney Romero | bromero@tannerpharma.com | +1 704 552 8408

###


About Tanner Pharma Group

For over 15 years, Tanner’s executive team has provided specialty distribution of pharmaceuticals from markets of availability to markets of need. When healthcare providers in international markets require treatments not currently available in their home market, they rely on Tanner to source and deliver the product from its global network of pharmaceutical manufacturers. Based on its track record of accountability and experience managing regulatory-compliant access programs, top pharmaceutical and biotech companies partner with Tanner to develop and manage their global access programs. By partnering with Tanner, pharma and biotech companies are able to focus on their primary markets while ensuring that patients in international markets of need are receiving their products through a strictly controlled channel.

Tanner’s International Access Division serves providers in 24 of the most challenging countries by developing, implementing and managing global access programs including Named Patient Programs, Expanded Access Programs, Compassionate Use Programs, Government & Private Provider Tender fulfillment and Emergency Supply allocations. Tanner’s Clinical Trials Division procures comparator products for manufacturers, CRO’s and research centers from a broad range of sources. Additionally, the company is able to provide clinical trial logistics and inventory management for trials conducted in the U.S., Europe, Mexico and Brazil.

Headquartered in the U.S., Tanner’s reach includes Europe, Northeast Asia, Southeast Asia, the Middle East, Australia, Canada and Latin America, including Brazil, Mexico, the Caribbean, Central America and all of South America.

For more information about Tanner Pharma Group, please visit www.tannerpharma.com.

For more information about Merz or the Company’s products, please visit www.merzusa.com.

Contact Us